Concepedia

Jörg Trappe

JT

Statistics

Publications

16

Citations

1.2K

H-Index

16

Active since

1995

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Tris Pharma (United States)

Ludwig-Maximilians-Universität München

Jörg Trappe is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1995–2020

16

Publications

16

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

Paul W. Manley, Peter Drueckes, Gabriele Fendrich et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2009 · 218 citations

, , +8

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing

O. Fedorov, K. Huber, Andreas Eisenreich et al. · Chemistry & Biology · 2011 · 194 citations · Full text

Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases

Peter Seibel, Jörg Trappe, Gaetano Villani et al. · Nucleic Acids Research · 1995 · 153 citations · Full text

Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited

B F Burkey, Peter Hoffmann, Ulrich Hassiepen et al. · Diabetes Obesity and Metabolism · 2008 · 110 citations

Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4

Robin A. Fairhurst, Thomas Knoepfel, Nicole Buschmann et al. · Journal of Medicinal Chemistry · 2020 · 106 citations · Full text

, , +19

1–5 of 16